675 related articles for article (PubMed ID: 11329263)
21. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
22. Coupling of Redox and Structural States in Cytochrome P450 Reductase Studied by Molecular Dynamics Simulation.
Iijima M; Ohnuki J; Sato T; Sugishima M; Takano M
Sci Rep; 2019 Jun; 9(1):9341. PubMed ID: 31249341
[TBL] [Abstract][Full Text] [Related]
23. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
24. Flavins of NADPH-cytochrome P-450 reductase: evidence for structural alteration of flavins in their one-electron-reduced semiquinone states from resonance Raman spectroscopy.
Sugiyama T; Nisimoto Y; Mason HS; Loehr TM
Biochemistry; 1985 Jun; 24(12):3012-9. PubMed ID: 3925989
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
26. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
Müller-Enoch D
Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
[TBL] [Abstract][Full Text] [Related]
27. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.
Vermilion JL; Ballou DP; Massey V; Coon MJ
J Biol Chem; 1981 Jan; 256(1):266-77. PubMed ID: 6778861
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic studies on the intramolecular one-electron transfer between the two flavins in the human neuronal nitric-oxide synthase and inducible nitric-oxide synthase flavin domains.
Guan ZW; Kamatani D; Kimura S; Iyanagi T
J Biol Chem; 2003 Aug; 278(33):30859-68. PubMed ID: 12777376
[TBL] [Abstract][Full Text] [Related]
29. Kinetic analysis of cytochrome P450 reductase from Artemisia annua reveals accelerated rates of NADH-dependent flavin reduction.
Simtchouk S; Eng JL; Meints CE; Makins C; Wolthers KR
FEBS J; 2013 Dec; 280(24):6627-42. PubMed ID: 24299267
[TBL] [Abstract][Full Text] [Related]
30. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
31. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
Haines DC; Sevrioukova IF; Peterson JA
Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
[TBL] [Abstract][Full Text] [Related]
32. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
33. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
34. An appraisal of multiple NADPH binding-site models proposed for cytochrome P450 reductase, NO synthase, and related diflavin reductase systems.
Daff S
Biochemistry; 2004 Apr; 43(13):3929-32. PubMed ID: 15049700
[TBL] [Abstract][Full Text] [Related]
35. Characterization of hydride transfer to flavin adenine dinucleotide in neuronal nitric oxide synthase reductase domain: geometric relationship between the nicotinamide and isoalloxazine rings.
Miller RT; Hinck AP
Arch Biochem Biophys; 2001 Nov; 395(1):129-35. PubMed ID: 11673874
[TBL] [Abstract][Full Text] [Related]
36. Short-lived neutral FMN and FAD semiquinones are transient intermediates in cryo-reduced yeast NADPH-cytochrome P450 reductase.
Davydov RM; Jennings G; Hoffman BM; Podust LM
Arch Biochem Biophys; 2019 Sep; 673():108080. PubMed ID: 31445894
[TBL] [Abstract][Full Text] [Related]
37. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
38. NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer.
Hubbard PA; Shen AL; Paschke R; Kasper CB; Kim JJ
J Biol Chem; 2001 Aug; 276(31):29163-70. PubMed ID: 11371558
[TBL] [Abstract][Full Text] [Related]
39. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
McLean KJ; Scrutton NS; Munro AW
Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197
[TBL] [Abstract][Full Text] [Related]
40. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]